Matiz Tablet contains Mebeverine 135 mg, an antispasmodic agent primarily used to relieve symptoms associated with irritable bowel syndrome (IBS) and other functional gastrointestinal disorders. Mebeverine acts directly on the smooth muscle of the gastrointestinal tract, exerting a spasmolytic effect without affecting normal gut motility. This action helps alleviate abdominal pain, cramps, bloating, and discomfort caused by intestinal spasms. Matiz Tablet is indicated for the symptomatic treatment of conditions characterized by intestinal spasm, including irritable bowel syndrome, diverticular disease, and other functional bowel disorders. The medication is generally well tolerated, with minimal side effects reported, such as mild gastrointestinal disturbances or allergic reactions in rare cases. It is contraindicated in patients with known hypersensitivity to Mebeverine or any of the tablet’s excipients. Dosage and administration should be as prescribed by a healthcare professional, typically taken orally before meals to maximize efficacy. Patients are advised to inform their physician of any pre-existing medical conditions or concurrent medications to avoid potential interactions. Matiz Tablet provides effective symptomatic relief, improving patient quality of life by targeting the underlying smooth muscle spasms responsible for gastrointestinal discomfort.